Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley Allen

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|March 8, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral BioavailabilityErik J Hicken, Fred P Marmsater, Mark C Munson, et al.
Journal of Medicinal Chemistry|December 10, 2021
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS<sup>G12D</sup> InhibitorXiaolun Wang, Shelley Allen, James F Blake, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG AffinityBruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|March 8, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral BioavailabilityErik J Hicken, Fred P Marmsater, Mark C Munson, et al.
Journal of Medicinal Chemistry|December 10, 2021
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS<sup>G12D</sup> InhibitorXiaolun Wang, Shelley Allen, James F Blake, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Design of Potent Menin-KMT2A Interaction Inhibitors with Improved <i>In Vitro</i> ADME Properties and Reduced hERG AffinityBruno D Chapsal, Jennifer R Kimbrough, Stephanie M Bester, et al.
Pageof 3